Ticker Coverage

ENSC

Dilution 10/10 · EXTREMEBy ShareStructure Research Desk · Aug 6, 2026

Ensysce Biosciences Faces 2.4x Float in Pending Supply From Death-Spiral Converts

With shares outstanding up roughly 520% in twelve months and an undrawn equity line that could add 50 million more shares, ENSC's structural overhang dwarfs its 13.6-million-share tradeable float.

Dilution 10/10 · EXTREMEBy ShareStructure Research Desk · Aug 4, 2026

Ensysce Biosciences Faces 2.4x Float in Pending Share Supply

A floating-rate preferred conversion mechanism has already driven a 520% increase in shares outstanding over twelve months, and roughly 32 million additional shares could enter the market within a year.